Key facts
- This page summarizes Erin E. Burkhart's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 23 Sep 2026, 16:17.
Erin E. Burkhart - 22 Sep 2026 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)
- Reporting relationship
- SVP, Controllership
- Issuer ticker
- GILD
- Reported as of
- 22 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Sep 2026, 16:17:14 UTC
- Prior SEC filing
- 12 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amy Kim by Power of Attorney for Erin E. Burkhart
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Erin E. Burkhart filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 23 Sep 2026.
Change
- Previous filing in this sequence was filed on 12 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001927648
Primary reporting owner
Burkhart Erin
- Relationship
- SVP, Controllership
- Address
- 333 LAKESIDE DRIVE, FOSTER CITY
- Signature
- /s/ Amy Kim by Power of Attorney for Erin E. Burkhart
- Signature date
- 23 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GILD
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +2,223
- Change %
- Price
- Shares after
- 2,223
- Date
- 22 Sep 2026
- Ownership
- Direct
- Footnotes
- F1
GILD
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -768
- Change %
- -35%
- Price
- $152.67*
- Shares after
- 1,455
- Date
- 22 Sep 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GILD
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -2,223
- Change %
- -20%
- Price
- Shares after
- 9,022
- Date
- 22 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,223
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Footnote F2
The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.